Literature DB >> 3886044

T-cell depletion of bone marrow does not inhibit in vitro hematopoiesis.

J Kirshner, H Ozer, M O'Leary, D Higby, M Marinello, H Preisler.   

Abstract

One approach to overcome the problem of histoincompatibility in bone marrow transplantation is to use T cell depleted marrow from a haploidentical donor in an attempt to ameliorate graft-versus-host disease. Since the T cell requirements for normal hematopoiesis are uncertain, experiments were performed to study the effects of E rosette-T cell depletion on in vitro growth of hematopoietic progenitor cells. Marrow mononuclear cells were cultured in a modified CFU-GEMM assay before and after T cell depletion. The number of 7 day granulocytic and erythrocytic colonies, and 14 day granulocytic, erythrocytic and mixed colonies were enumerated and expressed in terms of colonies per 10(5) non T cells plated. T cell depletion did not result in decreased proliferation of any of these progenitors save possibly for 14 day granulocytic colonies in one of four experiments. In two cases, T cell depletion resulted in increased growth of progenitor cells. Three of four patients transplanted with T cell depleted haploidentical marrow cells engrafted. It is concluded that E rosette depletion of T cells from marrow does not decrease the potential of these cells to establish hematopoiesis in vitro or in vivo.

Entities:  

Mesh:

Year:  1985        PMID: 3886044     DOI: 10.1007/bf00320295

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  9 in total

1.  Immunofluorescent analysis of blood cells by flow cytometry.

Authors:  R A Hoffman; W P Hansen
Journal:  Int J Immunopharmacol       Date:  1981

2.  The expression of histocompatibility-2 antigens on hemopoietic stem cells.

Authors:  J L Russell; G van den Engh
Journal:  Tissue Antigens       Date:  1979-01

3.  Culture studies of human pluripotent hemopoietic progenitors.

Authors:  H A Messner; A A Fauser
Journal:  Blut       Date:  1980-11

4.  Pretreatment of donor bone marrow with monoclonal antibody OKT3 for prevention of acute graft-versus-host disease in allogeneic histocompatible bone-marrow transplantation.

Authors:  A H Filipovich; P B McGlave; N K Ramsay; G Goldstein; P I Warkentin; J H Kesey
Journal:  Lancet       Date:  1982-06-05       Impact factor: 79.321

5.  Human peripheral blood erythroid burst forming unit (BFU(E)): evidence against T-lymphocyte requirement for proliferation in vitro.

Authors:  B Nomdedeu; B J Gormus; M Banisadre; J J Rinehart; M E Kaplan; E D Zanjani
Journal:  Exp Hematol       Date:  1980-08       Impact factor: 3.084

6.  Transplantation for acute leukaemia with HLA-A and B nonidentical parental marrow cells fractionated with soybean agglutinin and sheep red blood cells.

Authors:  Y Reisner; N Kapoor; D Kirkpatrick; M S Pollack; B Dupont; R A Good; R J O'Reilly
Journal:  Lancet       Date:  1981-08-15       Impact factor: 79.321

7.  Immunoregulatory T cell function in multiple myeloma.

Authors:  H Ozer; T Han; E S Henderson; A Nussbaum; D Sheedy
Journal:  J Clin Invest       Date:  1981-03       Impact factor: 14.808

8.  Human erythroid burst-forming unit: T-cell requirement for proliferation in vitro.

Authors:  D G Nathan; L Chess; D G Hillman; B Clarke; J Breard; E Merler; D E Housman
Journal:  J Exp Med       Date:  1978-02-01       Impact factor: 14.307

9.  Mature bone marrow erythroid burst-forming units do not require T cells for induction of erythropoietin-dependent differentiation.

Authors:  J M Lipton; E L Reinherz; M Kudisch; P L Jackson; S F Schlossman; D G Nathan
Journal:  J Exp Med       Date:  1980-08-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.